Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Trop Anim Health Prod ; 46(2): 371-7, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24197687

ABSTRACT

Trypanosoma evansi infection typically produces wasting disease, but it can also develop into a neurological or meningoencephalitis form in equids. Trypanosomiasis in horses was treated with quinapyramine sulfate, and all the 14 infected animals were recovered clinically. After clinical recovery, four animals developed a neurological form of the disease at various intervals. Two of these animals treated with diminazene aceturate recovered temporarily. Repeated attempts failed to find the parasite in the blood or the cerebrospinal fluid (CSF), but all of the animals were positive in enzyme-linked immunosorbent assay. The calculation of the antibody index (AI) in the serum and the CSF and polymerase chain reaction (PCR) analysis of the CSF and brain tissue were carried out to confirm the neuro-infection. We found PCR and AI analyses of the CSF to be useful tools in the diagnosis of the neurological form of trypanosomiasis when the organism cannot be found in the blood or CSF. The increased albumin quotient is indicative of barrier leakage due to neuroinflammation. The biochemical changes in the CSF due to nervous system trypanosomiasis include increases in the albumin quotient, total protein, and urea nitrogen. It seems to be the first report on relapse of the nervous form of trypanosomiasis in equids even after quinapyramine treatment in endemic areas.


Subject(s)
Blood-Brain Barrier , Central Nervous System Infections/veterinary , Horse Diseases/parasitology , Quinolinium Compounds/therapeutic use , Trypanosoma/isolation & purification , Trypanosomiasis/veterinary , Animals , Central Nervous System Infections/epidemiology , Central Nervous System Infections/parasitology , Diminazene/analogs & derivatives , Diminazene/therapeutic use , Disease Outbreaks/veterinary , Enzyme-Linked Immunosorbent Assay/veterinary , Horse Diseases/pathology , Horses , India/epidemiology , Trypanocidal Agents/therapeutic use , Trypanosoma/classification , Trypanosomiasis/parasitology , Trypanosomiasis/pathology
2.
Trop Anim Health Prod ; 45(2): 417-21, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22836485

ABSTRACT

Trypanosomiasis caused by Trypanosoma evansi commonly produces wasting disease with signs of emaciation and cachexia mainly at the end stage. The present study was conducted to explore the possible hyperlipaemia or hyperlipidaemia and its association with cachexia-anorexia in equine trypanosomiasis. Out of the fifteen confirmed animals, none of the plasma sample was opaque. There was a significant increase in plasma triglyceride, total cholesterol and blood urea nitrogen and a highly significant increase in low-density lipoprotein (LDL) levels. A mild increase in high-density lipoprotein (HDL) and very low-density lipoprotein levels were observed, while the relative percentage of HDL and LDL was altered with high significance. A moderate increase in triglyceride and highly significant increase in LDL might be the reasons for retention of appetite and lipolysis. Possible protein breakdown and presence of lipolysis might be the reasons for cachexia in equine trypanosomiasis.


Subject(s)
Anorexia/veterinary , Blood Urea Nitrogen , Cachexia/veterinary , Horse Diseases/physiopathology , Hyperlipidemias/veterinary , Lipids/blood , Trypanosomiasis/veterinary , Animals , Anorexia/parasitology , Anorexia/physiopathology , Appetite , Cachexia/parasitology , Cachexia/physiopathology , Horse Diseases/parasitology , Horses , Hyperlipidemias/parasitology , Hyperlipidemias/physiopathology , Spectrophotometry, Ultraviolet/veterinary , Trypanosoma/physiology , Trypanosomiasis/complications , Trypanosomiasis/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL
...